Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2010-12-23

Clinical Trial Update: Chantix & Bupropion for Smoking Cessation [Phase 3]

View source ↗

Summary

Phase 3 trial comparing Chantix (varenicline) with bupropion for smoking cessation has completed. Results were posted in 2010.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CHANTIX (varenicline tartrate)
  • bupropion (bupropion)

Snippet

Sponsor: Mayo Clinic | Conditions: Smoking, Tobacco Use Disorder | Phase 3 | Status: COMPLETED | Results posted: 2010-12-23